Institutional shares held 93.2 Million
257K calls
261K puts
Total value of holdings $534M
$1.47M calls
$1.49M puts
Market Cap $760M
132,638,000 Shares Out.
Institutional ownership 70.25%
# of Institutions 257


Latest Institutional Activity in VIR

Top Purchases

Q2 2025
Clarius Group, LLC Shares Held: 618K ($3.54M)
Q2 2025
Gsa Capital Partners LLP Shares Held: 67.8K ($389K)
Q2 2025
Diversified Trust CO Shares Held: 22.9K ($131K)
Q2 2025
Wealth Enhancement Advisory Services, LLC Shares Held: 16K ($91.6K)
Q2 2025
State Of Alaska, Department Of Revenue Shares Held: 55.1K ($316K)

Top Sells

Q2 2025
Gamma Investing LLC Shares Held: 1.34K ($7.66K)
Q2 2025
Vontobel Holding Ltd. Shares Held: 45.4K ($260K)
Q2 2025
Fifth Third Bancorp Shares Held: 651 ($3.73K)
Q2 2025
Louisiana State Employees Retirement System Shares Held: 43.3K ($248K)
Q2 2025
Parallel Advisors, LLC Shares Held: 468 ($2.68K)

About VIR

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.


Insider Transactions at VIR

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.74M Shares
From 16 Insiders
Grant, award, or other acquisition 514K shares
Other acquisition or disposition 1.22M shares
Sell / Disposition
1.43M Shares
From 11 Insiders
Open market or private sale 214K shares
Other acquisition or disposition 1.22M shares

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Track Activities on VIR